Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03200717
Title Study of Efficacy, Safety, and Quality of Life of Pazopanib in Patients With Advanced and/or Metastatic Renal Cell Carcinoma After Prior Checkpoint Inhibitor Treatment
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | FRA | ESP | DEU | CAN | AUT

Facility Status City State Zip Country Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Novartis Investigative Site Caba Buenos Aires C1280AEB Argentina Details
Novartis Investigative Site Graz 8036 Austria Details
Novartis Investigative Site Salzburg 5020 Austria Details
Novartis Investigative Site Wien A-1090 Austria Details
Novartis Investigative Site Calgary Alberta T2N 4N2 Canada Details
Novartis Investigative Site Temuco Araucania 4810469 Chile Details
Novartis Investigative Site Santiago 8420383 Chile Details
Novartis Investigative Site Brno Czech Republic 656 53 Czechia Details
Novartis Investigative Site Olomouc CZE 775 20 Czechia Details
Novartis Investigative Site Paris 75015 France Details
Novartis Investigative Site Strasbourg Cedex F 67098 France Details
Novartis Investigative Site Valenciennes 59300 France Details
Novartis Investigative Site Hannover 30625 Germany Details
Novartis Investigative Site Jena 07740 Germany Details
Novartis Investigative Site Tübingen 72076 Germany Details
Novartis Investigative Site Budapest H 1122 Hungary Details
Novartis Investigative Site Sevilla Andalucia 41013 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site London NW3 2QG United Kingdom Details
Novartis Investigative Site Manchester M20 2BX United Kingdom Details
Novartis Investigative Site Preston PR2 9HT United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field